Related Experiment Video

Updated: Feb 12, 2026

Generation of Recombinant Arenavirus for Vaccine Development in FDA-Approved Vero Cells
10:03

Generation of Recombinant Arenavirus for Vaccine Development in FDA-Approved Vero Cells

Published on: August 1, 2013

17.6K

By the Numbers: Novel Drugs Approved by the FDA, 2011-2017

    Cancer Discovery
    |April 4, 2018
    PubMed

    Insights

    In 2017, the U.S. Food and Drug Administration (FDA) approved 12 new cancer drugs and two groundbreaking chimeric antigen receptor T-cell therapies for blood cancers.

    Area of Science:

    • Oncology
    • Hematology
    • Pharmacology

    Background:

    • The U.S. Food and Drug Administration (FDA) plays a crucial role in regulating new drug approvals.
    • Advancements in cancer treatment have led to the development of novel therapeutic agents.

    Purpose of the Study:

    • To summarize the novel cancer drug and cell therapy approvals by the FDA in 2017.
    • To highlight key regulatory milestones in cancer treatment.

    Main Methods:

    • Review of FDA drug approval data for the year 2017.
    • Categorization of approved therapies based on drug type and target indication.

    Main Results:

    • Twelve novel cancer drugs received FDA approval in 2017.
    • Two chimeric antigen receptor T-cell therapies were approved for treating blood cancers.

    Conclusions:

    • 2017 marked a significant year for cancer therapeutics with multiple new drug and innovative cell therapy approvals.
    • FDA approvals provide patients with new options for managing and treating various cancers, particularly blood malignancies.

    More Related Videos

    The NeuroStar TMS Device: Conducting the FDA Approved Protocol for Treatment of Depression10:29

    The NeuroStar TMS Device: Conducting the FDA Approved Protocol for Treatment of Depression

    Published on: November 12, 2010

    40.6K
    Labeling Stem Cells with Ferumoxytol, an FDA-Approved Iron Oxide Nanoparticle05:05

    Labeling Stem Cells with Ferumoxytol, an FDA-Approved Iron Oxide Nanoparticle

    Published on: November 4, 2011

    21.7K

    Related Concept Videos

    FDA Approved Drugs: Changes to Approved Drugs01:26

    FDA Approved Drugs: Changes to Approved Drugs

    Post-approval, manufacturers may modify an approved new or generic drug product. Such modifications can encompass alterations in the Active Pharmaceutical Ingredient (API), manufacturing process, formulation, batch size, manufacturing site, and container closure system (FDA Guidance for Industry, April 2004). Often, a drug product may undergo multiple changes.These modifications require careful evaluation to determine their potential impact on the drug product's identity, strength, quality,...
    275
    Pharmacokinetics: Drug–Drug Interactions01:25

    Pharmacokinetics: Drug–Drug Interactions

    Drug interactions occur when the pharmacological effect of one drug is altered by another substance, either enhancing or diminishing its activity. The drug whose activity is altered is known as the object drug, and the substance causing the alteration is called the agent drug or the precipitant. The net effects of these interactions are mostly undesirable, leading to decreased effectiveness or increased adverse effects. In rare cases, interactions can be beneficial, such as the enhanced...
    465
    Bioequivalence of Drugs: Drugs with Multiple Indications01:09

    Bioequivalence of Drugs: Drugs with Multiple Indications

    The concept of therapeutic equivalence (TE) in drugs with multiple indications is complex. A generic drug may be therapeutically equivalent to a brand-name product for one specific indication, but this doesn't necessarily mean it's equivalent for all other indications. Evidence of TE in one patient group and bioequivalence shown in healthy volunteers can support—but not confirm—TE for other indications. However, definitive proof requires individual clinical studies for each...
    165
    Pharmacokinetics: Drug–Food and Drug–Viral Interactions01:26

    Pharmacokinetics: Drug–Food and Drug–Viral Interactions

    A drug interaction occurs when the concurrent use of another drug, food, or an external substance alters the pharmacological activity of a drug. This interaction can modify the action of the original drug, affecting its effectiveness and safety.Drug–food interactions are significant as they impact drug absorption, metabolism, and excretion. For example, grapefruit juice is a well-known disruptor of drug metabolism. It inhibits the cytochrome P450 3A4 enzyme, crucial for the metabolism of...
    262
    Factors Influencing Drug Absorption: Drug Dissolution01:27

    Factors Influencing Drug Absorption: Drug Dissolution

    The pharmacokinetic journey of drugs from solid oral dosage forms into systemic circulation is multifaceted. It begins with disintegration, a prerequisite ensuring a solid dosage form's subdivision into minute particles. Dissolution occurs next as these granulated entities solubilize in gastrointestinal fluids. This solubilization is crucial for the succeeding stage, permeation, which describes the traversal of the drug across the intestinal membrane and its subsequent entry into the blood...
    1.2K
    Factors Affecting Protein-Drug Binding: Drug-Related Factors01:18

    Factors Affecting Protein-Drug Binding: Drug-Related Factors

    Drug binding to proteins is a complex phenomenon influenced by various drug-related factors, each playing a significant role in the interaction between drugs and proteins within the body.
    One crucial factor in drug-protein binding is the drug's lipophilicity or its affinity for fat. More lipophilic drugs tend to have higher binding extents. For example, highly lipophilic drugs like cloxacillin exhibit substantial protein binding, with as much as 95% of the drug binding to proteins. In...
    492